| abstract |
The present invention provides a hNGAL mutein that binds to CGRP, and the mutein can be used in a variety of applications, including medical applications, such as migraine. The invention also relates to methods of making one or more muteins described herein, as well as compositions and combinations comprising one or more of the muteins. The invention further relates to nucleic acid molecules encoding such muteins and methods of producing such muteins and nucleic acid molecules. Furthermore, the application discloses the use of these muteins for the treatment and/or diagnosis as well as compositions and combinations comprising one or more such muteins. |